Ocugen Inc. OCGN
$1.19
▼ -0.82% 24H
About
Ocugen Inc. is a biopharmaceutical company headquartered in Malvern, Pennsylvania, specializing in the discovery, development, and commercialization of gene therapies, cell therapies, and vaccines. The company's primary focus centers on rare inherited retinal diseases, with its breakthrough modifier gene therapy platfo…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees116
TickerOCGN
Statistics
Market Cap$400.9M
Revenue (TTM)$4.4M
Net Income-$67.8M
Net Margin-1537.4%
EPS—
P/E-5.37
P/S92.50
P/B68.17
EV/EBITDA-6.33
ROE-660.0%
Dividend Yield—
Price$1.19
Data: Twelve Data · Revenue = mcap / P/S